Related Experiment Video
Updated: Nov 16, 2025

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
Published on: June 4, 2012
An unusual case of Cardiobacterium valvarum causing aortic endograft infection and osteomyelitis
Eric G Hauser1, Imran Nizamuddin2, Brett B Yarusi1
1Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Insights
Cardiobacterium valvarum, a rare HACEK organism, can cause serious infections beyond infective endocarditis, including aortic endograft infection and osteomyelitis in complex patients. This highlights the need for consideration in high-risk individuals with disseminated disease.
Area of Science:
- Infectious Diseases
- Microbiology
- Cardiology
Background:
- HACEK organisms cause 0.8%–6% of infective endocarditis cases.
- Cardiobacterium spp. is the third most common HACEK organism implicated.
- Cardiobacterium valvarum (C. valvarum) is a novel species identified in 2004, with limited reported cases.
Observation:
- A 57-year-old male with a history of aortic dissection and endograft replacement presented with back pain.
- Radiographic evidence revealed an infected aortic endograft, vertebral osteomyelitis, discitis, and epidural phlegmon.
- Blood cultures identified C. valvarum as the causative agent.
Findings:
- The patient received ceftriaxone; surgical intervention was deferred due to complex anatomy.
- The patient experienced septic cerebral emboli, leading to a cerebrovascular accident.
- This case demonstrates C. valvarum causing extra-cardiac manifestations, including endograft infection and osteomyelitis.
Implications:
- C. valvarum is an emerging pathogen that requires consideration in high-risk patients with subacute or disseminated infections.
- While typically causing infective endocarditis, C. valvarum can manifest in extra-cardiac sites.
- This case underscores the potential for C. valvarum to infect aortic endografts and cause vertebral osteomyelitis.
Background:
HACEK (Haemophilus spp., Aggregatibacter spp., Cardiobacterium spp., Eikenella corrodens, and Kingella spp.) group organisms are responsible for 0.8% to 6% of all infective endocarditis cases, with Cardiobacterium spp. being the third most commonly implicated HACEK microorganism. Within this genus is Cardiobacterium valvarum (C. valvarum), a novel organism described in 2004. To date, only 15 cases of C. valvarum infection have been reported in the English-language literature, and have primarily been cases of infective endocarditis in patients with valvular disease. C. valvarum has not been reported to cause infections spreading to the surrounding bone.
Case Presentation:
We present a case of a 57-year-old man with a history of aortic dissection followed by aortic endograft replacement who presented with back pain. He was found to have radiographic evidence of an infected aortic endograft, along with vertebral osteomyelitis, discitis, and epidural phlegmon. Blood cultures identified C. valvarum as the causative organism. The patient was treated with ceftriaxone and surgical intervention was deferred due to the patient's complex anatomy. His course was complicated by septic cerebral emboli resulting in cerebrovascular accident.
Conclusions:
This case report highlights C. valvarum, a rare and emerging HACEK group microorganism that warrants consideration in high-risk patients with evidence of subacute infection and disseminated disease. While C. valvarum classically presents as infective endocarditis, extra-cardiac manifestations have also been described. As demonstrated in this case, endograft involvement and osteomyelitis may occur in rare circumstances.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Aortic Regurgitation I: Introduction
Aneurysm III: Interprofessional Care

